Predict your next investment

Viroclinics Biosciences company logo
Corporation
HEALTHCARE | Medical Facilities & Services / Medical Laboratories & Research
viroclinics.eu

See what CB Insights has to offer

Founded Year

2001

Stage

Acq - Fin - III | Alive

About Viroclinics Biosciences

Viroclinics Biosciences is a virology contract research organization, serving the biopharmaceutical community with a broad range of preclinical, clinical diagnostic, assay development and clinical trial logistics services. Operating at a global level, Viroclinics is the preferred virology testing laboratory for several of the top-10 biopharmaceutical companies. Viroclinics’ experience with clinical and preclinical studies for viruses, including its specialty in respiratory viruses, puts the company at the forefront in supporting the development of vaccines, antibodies and antiviral compounds targeting viral infectious diseases.

Viroclinics Biosciences Headquarter Location

Rotterdam Science Tower Marconistraat 16

Rotterdam, 3029 AK,

Netherlands

+31 88-6684787

Latest Viroclinics Biosciences News

Davide Molho, DVM Joins Viroclinics Biosciences as Chief Executive Officer

Jul 20, 2020

News provided by Share this article ROTTERDAM, Netherlands, July 20, 2020 /PRNewswire/ -- Viroclinics Biosciences B.V. ("Viroclinics") today announced the appointment of life sciences industry veteran Davide Molho, DVM as the company's new Chief Executive Officer. Dr. Molho succeeds Bob van Gemen, PhD who has served as the company's CEO since 2011. This transition is part of a planned succession strategy. Dr. Molho's appointment will take effect on 1 August 2020. Davide Molho (PRNewsfoto/Viroclinics Biosciences) Bob van Gemen (PRNewsfoto/Viroclinics Biosciences) Dr. Molho joins Viroclinics from Evolution Research Group, where he served as CEO. Prior to ERG, he worked for almost two decades at Charles River Laboratories, most recently serving as President and Chief Operating Officer of the global organization. As CEO of Viroclinics, Dr. Molho will lead the company through its next phase of growth with a specific focus on driving revenue diversification in adjacent and novel therapeutic fields, as well as continued strategic expansion through acquisitions. "Davide's global leadership capabilities, extensive operational expertise within large organizations, and impressive M&A track record will be great assets to Viroclinics as we aim to further accelerate growth," said Bob van Gemen. "I am thrilled to transition the CEO role to Davide, and I am confident that Viroclinics, our customers and the communities we serve will benefit from his experience and vision." "Bob has done a tremendous job leading Viroclinics' journey to a market-leading clinical research organization," said Davide Molho. "I am excited to join an organization operating at the forefront of global immunology challenges and I look forward to working closely with the team to build on the company's market leadership and guide the business through its next phase of growth." Viroclinics Biosciences is a global leader in virology testing and laboratory services, with labs in Europe and China, and a global network of processing facilities across 20 countries that serve trials worldwide. The company will continue to focus on new market developments, virology related projects, and clinical trials. Virology targets include COVID-19, influenza, RSV, HBV, HPV and polio. Simultaneously, Viroclinics is excited by the prospects of its nascent entries into the fields of gene therapy and immuno-oncology. To further accelerate growth, multiple corporate initiatives will be explored, including strategic partnerships and acquisitions. "Davide brings a record of leadership and shareholder value creation at global contract research organizations, and we are very excited to have such a high-caliber executive to lead the next phase of Viroclinics' journey," said Thomas Tarnowski, Viroclinics board member and Managing Director at Summit Partners. "We believe adding Davide to the already strong team, positions the company ideally to continue building on the impressive momentum created by Bob and the Viroclinics team over the past decade." About Viroclinics Diagnostic Laboratory Viroclinics Diagnostic Laboratory is a leading virology contract research organization, serving the biopharmaceutical community with a broad range of preclinical, clinical (advanced molecular) diagnostic,  assay development and clinical trial logistics services. Operating at a global level, Viroclinics is the preferred virology testing laboratory for several of the top-10 biopharmaceutical companies. Viroclinics' extensive experience with clinical and preclinical studies for viruses, including its specialty in respiratory viruses, puts the company at the forefront in supporting the development of vaccines, antibodies and antiviral compounds targeting viral infectious diseases. Viroclinics is based in Rotterdam, Rijswijk, Schaijk, (The Netherlands) and employs more than 270 well-trained, dedicated scientists and technical experts. More information

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Viroclinics Biosciences

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Viroclinics Biosciences is included in 2 Expert Collections, including Health & Wellness Assessment.

H

Health & Wellness Assessment

2,359 items

Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes companies focused solely on fitness/sports performance

I

Infectious Disease

2,222 items

Entities aiding the surveillance, screening, prevention, diagnosis, treatment, and containment of infections & the maintenance of public wellbeing during outbreaks.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.